The Adoption of R in Japan's Pharma Industry Confirmation
Channel: R Consortium
Date: 2024-01-10

The Adoption of R in Japan’s Pharma Industry talk and panel discussion was led by key industry experts from the JPMA R Task Force Team. The webinar explored the usage and adoption of R in the pharmaceutical industry, specifically focusing on the findings of the JPMA Drug Evaluation Committee, R Task Force Team, and the JPMA Report. The report referenced various open source works and publications, including those from the R Consortium pilot submissions, Package Validation Hub, and webinar training.

Agenda: 
General Background by Rikimaru Nishimura
- PMDA: Highlighting the intricacies of submissions with R.
- JPMA R Task Force: Delving into past activities and shedding light on future initiatives.
JPMA Survey Report by Rikimaru and Yuki Matsunaga
- Background: Understanding the rationale and motivation behind the JPMA survey.
- Results: Discuss key findings and their implications for the industry.
Q&A Session 

#Rstats #Opensource #rprogramming 
 
Main Sections

00:00 Introduction
04:54 General Background by Rikimaru Nishimura
13:11 JPMA Survey Report by Rikimaru and Yuki Matsunaga
26:56 Conclusion
27:47 Q&As

More Resources 

Main Site: https://www.r-consortium.org/ 
DataTrail: https://www.datatrail.org/
Blog: https://www.r-consortium.org/news/blog 
Join: https://www.r-consortium.org/about/join 
LinkedIn: https://www.linkedin.com/company/r-consortium/  
Twitter:  https://twitter.com/rconsortium?lang=en
Mastodon: https://fosstodon.org/@RConsortium